Variables | Total population (N = 391) | Missing data | No eABT (N = 131) | eABT (N = 260) | p-value |
---|---|---|---|---|---|
Centre #1– no. (%) | 186 (48%) | 0 (0%) | 71 (46%) | 115 (56%) | 0.07 |
Sex (female)—no. (%) | 128 (33%) | 0 (0%) | 52 (40%) | 76 (29%) | 0.04 |
Age [IQR]—yr | 71 [63–79] | 0 (0%) | 70 [61–80] | 71 [64–78] | 0.66 |
BMI [IQR]—kg.m−2 | 25 [19–29] | 32 (8%) | 25 [19–29] | 24 [20–29] | 0.69 |
Gold score—no. (%) |  | 107 (27%) |  |  |  0.55 |
   1–2 | 46 (16%) |  | 15 (16%) | 31 (16%) |  |
   3 | 92 (32%) |  | 27 (28%) | 65 (34%) |  |
   4 | 146 (51%) |  | 53 (56%) | 93 (49%) |  |
Home oxygen—no. (%) | 156 (40%) | 0 (0%) | 55 (42%) | 101 (39%) | 0.58 |
Home NIV—no. (%) | 80 (20%) | 0 (0%) | 31 (24%) | 48 (18%) | 0.23 |
COPD frequent exacerbator—no. (%) | 85 (22%) | 0 (0%) | 33 (25%) | 52 (20%) | 0.74 |
Active smoker—no. (%) | 146 (43%) | 53 (14%) | 44 (39%) | 102 (45%) | 0.3 |
Charlson score [IQR] | 5 [4–6] | 0 (0%) | 5 [3–6] | 5 [4–6] | 0.53 |
Invasive mechanical ventilation at ICU day-1—no. (%) | 133 (34%) | 0 (0%) | 26 (20%) | 107 (41%) |  < 0.01 |
SAPS2 [IQR] | 36 [30–46] | 0 (0%) | 33 (28–41) | 37 (31–47) | 0.001 |
P. aeruginosa colonization | 33 (8%) | 0 (0%) | 10 (8%) | 23 (9%) | 0.85 |
ICU day-1 highest body temperature [IQR]—°C | 37.2 [36.6–37.9] | 0 (0%) | 37 [36.7–37.5] | 37.4 [37–38.2] |  < 0.001 |
ICU day-1 worst Glasgow score without sedation | 14 [11–15] | 0 (0%) | 14 [12–15] | 14 [11–15] | 0.14 |
ICU day-1 worst PaCO2 [IQR]—Torr | 74 [63–89] | 0 (0%) | 76 [62.5–89] | 74 [63–89] | 0.98 |
ICU day-1 worst PaO2/FiO2 [IQR]—Torr |  | 0 (0%) |  |  | 0.01 |
    >300 | 55 (14%) |  | 28 (21%) | 27 (10%) |  |
    200–299 | 241 (62%) |  | 77 (59%) | 164 (63%) |  |
    <200 | 95 (24%) |  | 26 (20%) | 69 (27%) |  |
ICU day-1 highest procalcitonin [IQR]—ng.mL−1 | 0.2 [0.1–0.5] | 193 (49%) | 0.1 [0.1–0.2] | 0.3 [0.1–0.6] |  < 0.001 |
Cardiogenic pulmonary oedema on ICU day-1—no. (%) | 174 (45%) | 0 (0%) | 58 (44%) | 116 (45%) | 1 |
Antibiotic therapy before ICU day-1—no. (%) | 105 (27%) | 0 (0%) | 21 (16%) | 84 (32%) |  < 0.01 |
IV steroid use within 24 h from ICU admission—no. (%) | 88 (23%) | 0 (0%) | 33 (25%) | 55 (21%) | 0.37 |